Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0001193125-26-294546

Options or other derivatives

  • Director acquired 32,341 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Morris Arlene Director 2026-07-01 Grant or award · Stock Option (Right to Buy) +32,341 32,341 D
Loading xslF345X06/ownership.xml…